Financial Support for Patients Taking VORANIGO®

ServierONE works with you to connect you to the right support programs and services that help with the cost of VORANIGO tablets.

We offer:

  • Support with insurance coverage and reimbursement
  • Financial assistance to help you pay for VORANIGO tablets
  • Prescription fulfillment through our network of specialty pharmacies and distributors
  • Tools and resources to navigate the world of insurance
  • Access to a one-on-one Patient Experience Manager

Click logo for Important Safety Information.

See All The Details for VORANIGO Financial Support Programs

The Copay Program Limits Copay Amounts for Patients with Commercial Insurance

The Copay Program lowers the out-of-pocket cost of VORANIGO for eligible patients with commercial prescription insurance to no more than $25 per prescription if your copay exceeds that amount.

  • U.S./Puerto Rico resident
  • Available to eligible patients with commercial/private insurance paying a portion of their cost
  • Patients participating in government prescription insurance are not eligible
  • Apply for the Copay Program at ServierONE-copay.com

Enroll in the Copay Program

Get Started ▸

If you are experiencing a gap in coverage, you may be eligible for our Bridge program. Please call 1-800-813-5905 to talk with a Patient Experience Manager today.

Key Features

Financial Assistance: The ServierONE Copay Program offers financial support to eligible patients to help cover copayments, coinsurance, or deductible costs associated with treatment.

Easy Enrollment: You can easily enroll in the Copay Program by completing a simple application process.

Supportive Services: In addition to copay assistance, the program may also provide access to support services, such as reimbursement navigation and financial counseling, to help alleviate the financial burden of treatment.

Renewable Benefits: Eligible patients may take advantage of the ServierONE Copay Program for multiple prescription refills, ensuring continued access to treatment without the added financial strain.

If you have questions, please call 1-800-813-5905 , Monday through Friday, 8 AM to 8 PM ET.

The Bridge Program Helps Patients Who Experience a Short-Term Insurance Coverage Gap

The Bridge Program is designed to provide a one-time, 1-month supply of VORANIGO to qualified patients who experience a short-term lapse in coverage. This program gives you access to VORANIGO while your insurance issues are being resolved.

You may be eligible for the Bridge Program if you meet the following criteria:
  • U.S./Puerto Rico resident
  • Commercially insured
  • Have completed the VORANIGO enrollment form

Apply to the Bridge Program via Fax

Complete the appropriate sections of the VORANIGO Enrollment Form and then work with your healthcare provider to complete it. Your healthcare provider will fax your completed form to the ServierONE Patient Support Program at 1-877-770-7102.

Download VORANIGO Program Enrollment Form

Key Features

Quick Response: Our program aims to respond promptly to patient needs, ensuring that individuals can continue treatment without significant delays.

Case Management: Patients enrolled in the ServierONE Bridge Program may receive individualized case management support to help navigate insurance coverage issues and other barriers to medication access.

If you have questions, please call 1-800-813-5905 , Monday through Friday, 8 AM to 8 PM ET.

The QuickStart Program Helps Patients Who Experience a Delay in Insurance Coverage

The QuickStart Program is intended for patients who experience an insurance coverage delay lasting five or more business days. If eligible, you will receive one 30-day supply as prescribed by your healthcare provider. If there is a further delay in coverage, you will receive another 30-day supply refill per Servier approval.

You may be eligible for the QuickStart Program if you meet the following criteria:
  • U.S./Puerto Rico resident
  • Commercially or government insured
  • Have completed the VORANIGO enrollment form

Apply to the QuickStart Program via Fax

Complete the appropriate sections of the VORANIGO Enrollment Form and then work with your healthcare provider to complete it. Your healthcare provider will fax your completed form to the ServierONE Patient Support Services at 1-877-770-7102.

Download VORANIGO Enrollment Form

Key Features

Covers insurance delays: Eligible new patients facing coverage delays of 5 or more business days may receive a prescription with an option for a refill, totaling 60 days, upon submission of a completed prior authorization.

Seamless process: QuickStart prescriptions will be reviewed and filled by ServierONE. If using a network specialty pharmacy, they will collaborate with ServierONE to ensure uninterrupted access to treatments.

If you have questions, please call 1-800-813-5905 , Monday through Friday, 8 AM to 8 PM ET.

The Patient Assistance Program (PAP) Helps Uninsured and Underinsured Patients Access Important Treatments

PAP is dedicated to assisting uninsured and underinsured patients by offering medication to those who meet our eligibility criteria. This program is designed to ensure that financial constraints do not hinder access to a prescribed Servier treatment. The benefits of PAP are valid for a year.

You may be eligible for PAP if you meet the following criteria:
  • U.S./Puerto Rico resident
  • May apply if you have commercial or state/government insurance
  • Have completed the VORANIGO enrollment form
  • Financial Qualification: Household gross annual income does not exceed 600% of the US Federal Poverty Level
  • If you don’t meet these criteria, other forms of assistance may be available

If you have questions about qualifying, call us at 1-800-813-5905 for further assistance

Apply to PAP via Fax

Fill out the appropriate sections of the VORANIGO Enrollment Form and then work with your healthcare provider to complete it. Your healthcare provider will fax your completed form to ServierONE Patient Support Program at 1-877-770-7102.

Download VORANIGO Enrollment Form

Support Through Independent Foundations Is Also Available

Other forms of assistance may be available, including assistance from independent foundations for patients with government and commercial insurance. Network specialty pharmacies or Servier can provide a referral to one of these foundations. Eligibility is determined by the individual foundation. Servier is not affiliated with these organizations but can assist you in navigating eligibility.

Download List of Independent Foundations

How to enroll in the Patient Assistance Program (PAP)

1

Prescription & Enrollment Form
After you receive a prescription for VORANIGO from your healthcare provider, work with them to complete the VORANIGO Enrollment Form. Your HCP will fax it to ServierONE at 1-877-770-7102.

2

Benefit Investigation
One of our ServierONE team members will review your insurance coverage. If you are uninsured or VORANIGO is not covered by your insurance company, you will proceed to the next step.

3

Other Assistances
Other forms of assistance may be available, including assistance from independent foundations for patients with governmental and commercial insurance. Servier can provide information on a independent foundations that may be available to eligible patients. These foundations are not affiliated with Servier and operate independently. Please contact each foundation directly to obtain more information about eligibility and application processes.

4

Financial Criteria/Qualifications
One of our ServierONE team members will confirm that you meet the eligibility criteria for PAP.

5

Enrollment Complete
If you are approved, you will be enrolled in PAP for a calendar year.

If you do not meet the eligibility criteria, ServierONE Patient Assistance Program may be able to identify alternate sources of coverage.

Key Features

Overview: The Servier Patient Assistance Program provides uninsured and underinsured patients access to their treatment as needed by offering medication to those who meet our eligibility criteria.

Enrollment: Our dedicated program representatives are available to support patients with the application process, including guidance on required = 'true' documentation and eligibility requirements.

If you have questions, please call 1-800-813-5905 , Monday through Friday, 8 AM to 8 PM ET.

How VORANIGO® Prescriptions Are Filled for You

Because VORANIGO is a specialty medication, it’s unavailable through your local drugstore. Once your doctor sends in your prescription, you can get VORANIGO through a specialty pharmacy (a mail-order pharmacy that provides specialty drugs), your doctor’s office, or your hospital pharmacy.

Have Questions About Getting VORANIGO? Call Us Today at 1-800-813-5905.

Throughout the process, your specialty pharmacy or Servier may contact you by phone. Please keep in mind that this call may come from a number you do not recognize.

If you have questions, please call 1-800-813-5905 , Monday through Friday, 8 AM to 8 PM ET.

VORANIGO® IMPORTANT SAFETY INFORMATION AND INDICATIONS

What is VORANIGO?

VORANIGO (40 mg tablets) is a prescription medicine used to treat adults and children 12 years of age and older with certain types of brain tumors called astrocytoma or oligodendroglioma with an isocitrate dehydrogenase-1 (IDH1) or isocitrate dehydrogenase-2 (IDH2) mutation, following surgery. Your healthcare provider will perform a test to make sure that VORANIGO is right for you. It is not known if VORANIGO is safe and effective in children under 12 years of age.

What are the possible side effects of VORANIGO?

VORANIGO may cause serious side effects, including:

  • Liver problems. Changes in liver function blood tests may happen during treatment with VORANIGO and can be serious. Your healthcare provider will do blood tests to check your liver function before and during treatment with VORANIGO. Tell your healthcare provider right away if you develop any of the following signs and symptoms of liver problems:
    • yellowing of your skin or the white part of your eyes (jaundice)
    • dark tea-colored urine
    • loss of appetite
    • pain on the upper right side of your stomach area
    • feeling very tired or weak

The most common side effects of VORANIGO include:

  • increased liver enzyme levels in the blood
  • lack of energy, tiredness
  • headache
  • COVID-19
  • muscle aches or stiffness
  • diarrhea
  • nausea
  • seizure

Your healthcare provider may change your dose, temporarily stop, or permanently stop treatment with VORANIGO if you have certain side effects.
VORANIGO may affect fertility in females and males, which may affect the ability to have children. Talk to your healthcare provider if this is a concern for you. These are not all of the possible side effects of VORANIGO.

Before taking VORANIGO, tell your healthcare provider about all of your medical conditions, including if you:

  • have liver problems
  • have kidney problems or are on dialysis
  • smoke tobacco
  • are pregnant or plan to become pregnant. VORANIGO can harm your unborn baby

Females who are able to become pregnant:

  • Your healthcare provider will do a pregnancy test before you start treatment with VORANIGO
  • You should use effective nonhormonal birth control during treatment with VORANIGO and for 3 months after the last dose. VORANIGO may affect how hormonal contraceptives (birth control) work and cause them to not work well. Talk to your healthcare provider about birth control methods that may be right for you during treatment with VORANIGO
  • Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with VORANIGO

Males with female partners who are able to become pregnant:

  • You should use effective birth control during treatment with VORANIGO and for 3 months after the last dose
  • Tell your healthcare provider right away if your partner becomes pregnant or thinks she may be pregnant during your treatment with VORANIGO

Tell your healthcare provider if you are breastfeeding or plan to breastfeed. It is not known if VORANIGO passes into breast milk. Do not breastfeed during treatment with VORANIGO and for 2 months after the last dose.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. VORANIGO may affect the way other medicines work, and other medicines may affect how VORANIGO works.

What is VORANIGO?

VORANIGO (40 mg tablets) is a prescription medicine used to treat adults and children 12 years of age and older with certain types of brain tumors called astrocytoma or oligodendroglioma with an isocitrate dehydrogenase-1 (IDH1) or isocitrate dehydrogenase-2 (IDH2) mutation, following surgery. Your healthcare provider will perform a test to make sure that VORANIGO is right for you. It is not known if VORANIGO is safe and effective in children under 12 years of age.

What are the possible side effects of VORANIGO?

VORANIGO may cause serious side effects, including:

  • Liver problems. Changes in liver function blood tests may happen during treatment with VORANIGO and can be serious. Your healthcare provider will do blood tests to check your liver function before and during treatment with VORANIGO. Tell your healthcare provider right away if you develop any of the following signs and symptoms of liver problems:
    • yellowing of your skin or the white part of your eyes (jaundice)
    • dark tea-colored urine
    • loss of appetite
    • pain on the upper right side of your stomach area
    • feeling very tired or weak

The most common side effects of VORANIGO include:

  • increased liver enzyme levels in the blood
  • lack of energy, tiredness
  • headache
  • COVID-19
  • muscle aches or stiffness
  • diarrhea
  • nausea
  • seizure

Your healthcare provider may change your dose, temporarily stop, or permanently stop treatment with VORANIGO if you have certain side effects.
VORANIGO may affect fertility in females and males, which may affect the ability to have children. Talk to your healthcare provider if this is a concern for you. These are not all of the possible side effects of VORANIGO.

Before taking VORANIGO, tell your healthcare provider about all of your medical conditions, including if you:

  • have liver problems
  • have kidney problems or are on dialysis
  • smoke tobacco
  • are pregnant or plan to become pregnant. VORANIGO can harm your unborn baby

Females who are able to become pregnant:

  • Your healthcare provider will do a pregnancy test before you start treatment with VORANIGO
  • You should use effective nonhormonal birth control during treatment with VORANIGO and for 3 months after the last dose. VORANIGO may affect how hormonal contraceptives (birth control) work and cause them to not work well. Talk to your healthcare provider about birth control methods that may be right for you during treatment with VORANIGO
  • Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with VORANIGO

Males with female partners who are able to become pregnant:

  • You should use effective birth control during treatment with VORANIGO and for 3 months after the last dose
  • Tell your healthcare provider right away if your partner becomes pregnant or thinks she may be pregnant during your treatment with VORANIGO

Tell your healthcare provider if you are breastfeeding or plan to breastfeed. It is not known if VORANIGO passes into breast milk. Do not breastfeed during treatment with VORANIGO and for 2 months after the last dose.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. VORANIGO may affect the way other medicines work, and other medicines may affect how VORANIGO works.


Chat bubble

Support Bot

Online

This information is intended for U.S. Healthcare Professionals only. Click the CONTINUE button below to go to the page requested.

If you are a patient or caregiver, click the PATIENT button.

You are now leaving the ServierONE website to go to a Third Party Resource. Do you want to proceed?